Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Catherine Hollerbach
BCL-Xl Is Qualitatively Different From and Ten Times More Effective Than BCL-2 When Expressed in a Breast Cancer Cell Line
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Apoptosis Is Augmented in High-Grade Serous Ovarian Cancer by the Combined Inhibition of BCL-2/BCL-xL and PARP
International Journal of Oncology
Cancer Research
Oncology
HSpin1, a Transmembrane Protein Interacting With BCL-2/BCL-xL, Induces a Caspase-Independent Autophagic Cell Death
Cell Death and Differentiation
Cell Biology
Molecular Biology
Proteasome and HDAC Inhibition Changes the Expression Levels of BCL-2, BCL-Xl, Bim and Bik Proteins in Androgen-Independent PC-3 Cell Line
Gazi Medical Journal
Medicine
ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
BCL-xL in Neuroprotection and Plasticity
Frontiers in Physiology
Physiology
BH4 Domain Peptides Derived From BCL-2/BCL-Xl as Novel Tools Against Acute Pancreatitis
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
Different Expression Patterns of BCL-2, BCL-Xl, and Bax Proteins After Sublethal Forebrain Ischemia in C57Black/Crj6 Mouse Striatum
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Combined Inhibition of Notch Signaling and BCL-2/BCL-xL Results in Synergistic Antimyeloma Effect
Molecular Cancer Therapeutics
Cancer Research
Oncology
Venetoclax Is Effective in Small Cell Lung Cancers With High BCL-2 Expression
Clinical Cancer Research
Cancer Research
Oncology
